Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie)
1 other identifier
interventional
120
1 country
1
Brief Summary
First, investigators must determine the physiological standards across age classes of myocardial stiffness estimated by Elastography in ultrafast (estimated right ventricular stiffness \[VD\] and left ventricular \[LV\]). This will be done in groups of children without heart condition, age group (10 children per group, four age groups \[0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years\]). Secondly, investigators will evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with cardiomyopathy and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values. The total population of the study will be 120 children (40 healthy, 80 patients).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2015
CompletedStudy Start
First participant enrolled
November 1, 2015
CompletedFirst Posted
Study publicly available on registry
December 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2017
CompletedNovember 6, 2017
October 1, 2017
1.5 years
October 23, 2015
October 31, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Myocardial diastolic stiffness UltrafastEcho (kPa)
Normal values and intra-observer variability and inter-observer variability to demonstrate that the Aixplorer® myocardial elastography provides a reproducible assessment of myocardial stiffness.
through study completion, an average of 1 year
Study Arms (3)
Group 1 "healthy volunteers
OTHEREchography and Elastography To determine physiological standards across age classes of myocardial stiffness estimated by Elastography in ultrafast (estimated right ventricular stiffness \[VD\] and left ventricular \[LV\]). This will be done in groups of children without heart condition, age group (10 children per group, four age groups \[0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years\]).
Group 2 Patients CMH primitive
OTHEREchography and Elastography To evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with Hypertrophic Cardiomyopathy (HCM) non obstructive primitive and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values.
Group 3 Patients primitive CMD:
OTHEREchography and Elastography To evaluate myocardial stiffness Elastography (RV and LV) on different groups of children (same age group) with Dilated Cardiomyopathy primitive and examine correlations with the conventional parameters of systolic and diastolic function of both ventricles and with myocardial strain values.
Interventions
cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and measurement of all echocardiographic parameters estimated in children with a clinical ultrasound Machine
cardiac ultrasound, in two stages, with an estimate of the stiffness of the myocardium ShearWave Elastography (Aixplorer®) and
Eligibility Criteria
You may qualify if:
- Group 1. Healthy Age criteria met by group \[0-1mois, 1 month-1 year 1 year-5 years, 5 years-15years\]
- consultation for heart murmur
- Recipient of a social protection scheme or entitled (excluding AME)
- Signed informed consent by the holders of parental authority
- Group 2. Patients MHC nonobstructive:
- Age criteria met by group \[1 month-1 year 1 year-5 years\]
- Diagnostic criteria of non-obstructive HCM validated by the medical team of pediatric cardiology center (Necker)
- Recipient of a social protection scheme or entitled (excluding AME)
- Signed informed consent by the holders of parental authority
- Group 3. Patients primitive CMD:
- Age criteria met by group \[1 month-1 year 1 year-5 years\]
- Diagnostic criteria of primary CMD validated by the medical team of pediatric cardiology center (Necker)
- Recipient of a social protection scheme or entitled (excluding AME)
- Signed informed consent
You may not qualify if:
- Group 1. Healthy Patients:
- Age\> 15 years
- Heart and Systemic Pathology identified
- metabolic and tissue pathology.
- known genetic pathology may have cardiac involvement.
- No echogenicity,
- Allergy echocardiography gel.
- Group 2. Group CMH primitive Patients
- No echogenicity,,
- Allergy echocardiography gel.
- Arrhythmia.
- Pacemaker or defibrillator
- Group 3. Patients primitive CMD:
- No echogenicity,,
- Allergy echocardiography gel.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Necker
Paris, 75005, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Olivier VILLEMAIN, MD
LAngevin Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 23, 2015
First Posted
December 2, 2015
Study Start
November 1, 2015
Primary Completion
May 1, 2017
Study Completion
July 1, 2017
Last Updated
November 6, 2017
Record last verified: 2017-10